In short
Podcast Notes: CNBC's "Fast Money" - AI’s Next Big Test.. And China Tech Climbs (9/8/25)
Episode Overview In this episode of CNBC’s "Fast Money," hosted by Melissa Lee, the discussion centers around the performance of AI stocks, the challenges in tech adoption, and the recent rise of Chinese tech stocks despite disappointing export data. The episode features insights from top traders, including Tim Seymour, Dan Nathan, and Mike Coe.
---
Key Topics and Discussions
- The AI Trade
- Broadcom's Performance:
- Shares continue to rally post-earnings, gaining 3% after announcing a new $10 billion AI client.
- Broadcom's market capitalization increased by $185 billion in just two trading sessions.
- NVIDIA's Recovery:
- After struggling post-earnings, NVIDIA saw a minor recovery of nearly 1% due to positive market sentiment surrounding AI.
- Meta's Investment in AI:
- Mark Zuckerberg's comments on increasing investments in AI contributed to the overall bullish sentiment in tech stocks.
- Concerns Over AI Adoption:
- Recent data indicates a slowdown in AI adoption among major companies, raising questions about the sustainability of current stock valuations.
- Apple’s Upcoming iPhone Launch
- Anticipation builds around Apple's iPhone event. Analysts expect a focus on hardware improvements rather than AI integration.
- Discussion on whether the new features are enough to excite investors and drive stock performance.
- Tesla's Market Challenges
- Tesla’s market share in the U.S. drops to below 40%, its lowest since 2017, as competition increases.
- The company is facing pressure as it shifts focus to other initiatives while rivals expand their EV offerings.
- Chinese Tech Stocks Surge
- Chinese stocks are witnessing a boost, with major players like Baidu and Alibaba nearing 52-week highs, despite a significant drop in exports to the U.S.
- Analysts suggest that the decline in exports might not hinder growth as China diversifies its markets.
- Fast Casual Restaurants Under Pressure
- Stocks of fast-casual brands like Chipotle and Sweetgreen are declining due to changing consumer habits and rising meal prices.
- Investment Strategies
- Discussion on differentiating between 'haves' and 'have-nots' in the tech sector, particularly regarding AI investments.
- Insights into market behaviors and expectations regarding future capital expenditure among major players in tech.
---
Key Takeaways
- Broadcom and AI: The rapid rise in Broadcom's stock highlights the potential of AI-related investments, but concerns about actual adoption rates could impact future performance.
- Market Sentiment: The overall tech market remains bullish, but caution is advised due to fluctuating adoption rates and competition.
- China's Resilience: Despite disappointing export data, the diversification of Chinese exports suggests resilience and potential for future growth in tech sectors.
- Restaurant Sector Trends: The decline in fast-casual stocks signals a shift in consumer preferences, posing challenges for companies in this space.
- Investment Perspectives: The conversation emphasizes a need for careful analysis of market trends and fundamentals when making investment decisions.
---
Conclusion The episode provides a comprehensive analysis of the current state of AI stocks, the challenges facing major tech companies like Apple and Tesla, and the unexpected rise of Chinese tech stocks amidst adverse export conditions. The discussions reinforce the notion that while there are opportunities in the tech sector, cautious optimism and strategic investment approaches are essential moving forward.
For more insights, watch "Fast Money," airing weeknights at 5 PM ET on CNBC.
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Transcript
Automatic transcript. May contain errors.0:00Hi, it's Melissa. Before we jump into today's show, I've got something exciting to share. On December 11th, we are hosting a special edition of Fast Money Live, trading the holidays right here at the NASDAQ Market Site. You get to watch a live taping of Fast Money, meet and interact with the traders, and, of course, celebrate the holiday season with us. It's stocks and cheers in the heart of the city, Times Square in December. You will not want to miss this. Tickets are available now at CNBCEvents.com slash Fast Money. Live from the NASDAQ Market Site in the heart of New York City's Times Square, this is Fast Money.
0:31Here's what's on tap tonight. AI ambitions, Broadcom's rally showing no signs of slowing, and NVIDIA getting back in on the action. What we know now about investment in AI and how much more it could propel the stocks. And Apple's big reveal, we are counting down to tomorrow's iPhone event in Cupertino. Can the tech giant get investors excited again? And will its focus on hardware over AI get the stock back in rally mode? Plus, trouble for Tesla as the EV company's market share hits multi-year lows. China tech stocks jump to near 52-week highs, and fast food falters. What is behind the indigestion in shares of Chipotle, Cava and more?
1:07I'm Melissa Lee coming to you live from Studio B at the NASDAQ. On the desk tonight, Tim Seymour, Dan Nathan and Mike Coe. We start off with the latest for the AI trade. Chairs of Broadcom continuing their post earnings run, adding another 3 % after the company said last week it scored a new$10 billion AI client. The stock has now gained$185 billion in market cap in just two trading sessions. The move helping the NASDAQ climb to new records today, even NVIDIA, which has been struggling since its earnings report, caught a bit today, rising almost a percent. One big catalyst for the rally, comments from Mark Zuckerberg that Meta could invest even more than the$600 billion he's been talking about lately in AI over the next few years.
1:46But new data from the U.S. Census Bureau suggests AI adoption by the country's biggest companies is actually slowing in recent months. And at Apple's big iPhone launch tomorrow, The tech giant is expected to focus on new hardware rather than its Apple intelligence offering. So how do these factors weigh in on the AI trade and the stocks that have led the pack? But first, let's sort of dissect what's going on with Broadcom, the message it sent, and then that report today that was highlighted by Torsen Slock of Apollo over the weekend. Yeah, a great chart packet there, you know what I mean, about some of the things, the concentration, I think, to some degree today in his note, I think it's the daily spark, just in general of the top 10 names in the NASDAQ.
2:28But the other thing, and this is what you're talking about, I think it was on Friday or so, we're seeing CapEx, which is exploding, and we see, like you just showed that tweet, by all the major CEOs, and it seems like this is the sort of thing that at any point could drop off if you see the adoption of some of these products or you don't see an acceleration in them one way or the other. And I'll just go back to what I think is a really important point. I mean, OpenAI is this customer of NVIDIA, and now it's a customer of Broadcom. I think that was one of the reasons why Thursday afternoon, when the stock really took off in the aftermarket, despite what looked like a good beat and raise, but not an excellent beat and raise, is that now they have a new$10 billion customer.
3:08This is OpenAI, and they're going to be doing custom silicon. And OpenAI was a huge customer of NVIDIA. And that's the story as it's broadening out right there. But OpenAI is expected to lose$115 billion through the end of 2029. The information reported that. So when you think about just those massive sort of losses, at some point, if you don't have the adoption, if you don't have the revenue that is going to justify that sort of spend, that will get pulled back. It's just that simple. And there's a lot of folks in that ecosystem that the stocks have pulled forward a lot of that expected performance one way or another.
3:44Is it early? I mean, I know that people will say, oh, no, the AI trade, it's been intact for three years or more even. But isn't it early in terms of the ways company can actually adopt and use and see the results? I think it is. The question is, where are we in the capex and the build-out period? Certainly for the broader industrial space and for kind of traditional C-suite operational evolution and where that means margin accretion for the rest of the S &P, I think we're very, very early. And I think part of the reason someone like Meta has outperformed here, even on some level, you can make an argument, most of the other chip players other than NVIDIA is because, in fact, they are seeing the benefit right now in their core business and the acceleration and the margin profile.
4:28Back to Broadcom, part of the story here, and I think this was part of the conversation we had on Friday, and to remind, which is that Broadcom truly by name is not just purely a semiconductor chip in the form of large language model and all that has been at least driving a lot of the NVIDIA. It is in wireless. It really is part of a data center play. And that's part of why I think the sense was, at least for the market that wanted some rotation into a more expensive company, by the way, that's part of the sustainability here. But I think we are early. And I think I know it was, you know, wherever we all were on that day of deep seek.
5:02Was that January? I forget when that was. Last week of January. But it was something that was profound because that was the moment we questioned whether all this CapEx made sense. And until we know otherwise, we do know that it's at least$500 billion from the hyperscalers. They alone, let alone everybody else. So, you know, again, I think there are different winners and losers along the road at different periods here. But the market right now, and we'll get to this, and my final point is that I think this is the last couple of days. It's all about the Fed. It's all about interest rates. But to make that point, Tim, on the AI, I mean, Friday was a great split screen.
5:34You had Broadcom that gained$150 billion in market cap, or actually more because of this huge order that they had relative to CapEx. On the flip side of it, if the next trade, before we get to the rest of the S &P and what they are going to do to monetize whatever spend or the uptake that they're going to have for AI tools, Salesforce was down 10 % or something at one point because they are not able to articulate how their customers are using this technology, right? And so when I think about, you know, CRM has a$240 billion market cap. That's almost equivalent to what, you know, Broadcom has gained in the last week or so.
6:11And so if you are going to start to see companies that are going to accrue that value or see an uptake from their customers, it should be in this application layer. And that is Salesforce. And they're getting it, I think, from productivity within their own company, but they're not getting their customers to spend or to pay up from their existing services. Mike, where do you fall on this? I mean, the four largest hyperscalers are more than tripling their CapEx between 2023 and the end of 2026. And I think the point that Dan is making because OpenAI's losses, I mean, obviously, they haven't figured out a way to monetize all of this.
6:43The four biggest hyperscalers are profitable, but their revenues aren't growing as fast as their CapEx spend. So we can't expect that to be sustainable. You know, look, it's a very good time to be in that space. That much is clear. A lot more money is going to be spent. That is also very clear. but the pace of growth is going to have to slow sooner or later. You mentioned the Fed, and I think that's a key point in terms of lower rates. I mean, we're at 4.07 percent or so on the 10-year yield. I spoke to Dan Niles earlier on the exchange today, and he basically said we're in an era of easy money.
7:17I mean, the Fed is easing, and so, yeah, keep investing. And so, you know, the higher growth companies, especially the ones with less profitability, the ones where you're discounting farther out in the future, I mean, lower rates, this is a bonanza. And financial conditions, I think, are wild. And I don't, you know, that's a little scary, but it's not necessarily time to pull back. And, again, I think if you just get back to, I mean, like a Salesforce and getting into, like, the haves and the have-nots in the AI trade, Salesforce has been a have-not for five years. Oracle has been a have, and yet Oracle is spending a lot of money on the low margin trades.
7:54They're growing revenues, big deals. So the market is rewarding, I think, the incremental growth. And again, back to Broadcom, the fact is that 60 percent growth in AI was exceeded and then they drop in the new customer and then it's a broader play. So I'm not going to, you know, don't fight the Fed. Don't fight necessarily some of these trends here in terms of the spend, but in terms of at least where we have it. I'll say this. I know I've said this 50 times. Here's 51. The sovereign AI trade has only begun. Think of all the countries around the world that are so slow to actually build out and the kind of cap backs and the support they're going to need on the private sector.
8:31And that private sector, a lot of it's in Silicon Valley or other parts that have a similar address to all the companies that we're talking about right now. So I think we are early. And I think the valuation dynamic is important. But as we've said many times, valuation is not going to knock these stocks down. Tech companies are like commodity companies. You don't buy them when they're cheap. You buy them when they're expensive. Yeah, well, I think I could take the other argument about sovereign AI right here. You saw what happened last week with China, with India, with Russia. I mean, the list goes on and on.
9:03I mean, I think that whatever that forum was or they put that committee together, I mean, that is like 35, 40 percent of the world's population. So if we're starting to see this sort of fracture between, let's say, the east and the west, and we're going to have a bipolar world. And if you think about the Belt and Road that China has instituted for the last 20 years, they're going to have a digital Belt and Road. I mean, that's happening right now. So the opportunity for a lot of our companies that are very innovative here, make no mistake about it, to have access, let's say, to the Chinese markets.
9:33We don't have any digital companies in China. Just think of all these massive, you know, tech companies that we have. I mean, yeah, we have Apple and, you know, Microsoft has had a huge issue with technology transfer and all those sorts of things for years. So there's a scenario where sovereign AI does not play out for the companies here that are building these sorts of chips. Look what's going on with these export bands that we have, you know, with NVIDIA. You can take both sides of it, but there is a chance that Huawei is innovating at a pace that they're going to be a great competitor to some of the chip makers that we have.
10:03So I think geopolitics has the potential to play a big role. Well, it has a huge, I mean, and that's why the China trade is really important. And China is a different place. I mean, the Russian economy is the size of Cleveland. I mean, I don't care about Russia. I don't really care about India here. And I care about U.S. companies that have continued to dominate global tech and I think are going to continue to dominate. And I'm sure China is going to be an adversary. I'm sure they're driving a wedge. But that's part of the story that I think around the biggest tech companies in the world, why we have been concerned about Apple in China.
10:30We have been concerned at least about a couple other players. But a lot of the other guys aren't even really counting China outside of NVIDIA and Apple. So we'll see. Well, investors are still closely watching the Apple event, how Apple incorporates AI into its newest devices at tomorrow's big event. Craig Moffitt is partner and senior managing director at Moffitt Nathanson. He's got a neutral rating on Apple, upgrading it from a sell rating last Thursday. So incrementally, I guess, less bearish on the name. Craig, it's always great to speak with you. Good seeing you, Melissa. I feel like we're counting down.
10:59We had a countdown clock on CNBC earlier, you know, 20 hours to this event. But I almost feel like this is the most inconsequential Apple iPhone launch in a long time because it doesn't have it. It's so ordinary. It's so pedestrian in terms of new hardware upgrades, you know, new new camera, better battery, thinner. You know, of course, it's got it. I mean, it's going to have a new phone. It's got to be thinner. It's got to have a better battery. It's got to have a better camera. Absolutely right. And in fact, the fact that you were able to just recite that litany of what we're going to see tomorrow tells you that we already know what we're going to see tomorrow.
11:34So it's almost impossible for this to be a meaningful event for the stock tomorrow. We know what we're going to see. We're going to see a thinner iPhone. That'll be probably more expensive. It's also not clear that people are going to want the thinner iPhone because coming with a thinner iPhone is less battery life. And I'm not sure people are going to be all that eager to make that trade-off. So at the end of the day, as you said, it's just not a terribly consequential day for Apple. At the same time, Craig, what is factored into the valuation, which is granted, you know, I guess you can look at it as expensive for a 10 percent revenue grower.
12:14You know, the P.E. is more expensive than a Meta or an Alphabet or a lot. It's not close to a 10 percent revenue grower. OK, so not even even worse. But you make my point there, Craig. I mean, what is factored in here? Is it enough that there is a normal upgrade cycle that people like me with an iPhone 11 will upgrade the phone because I have to? It's got a cracked screen. Or do we have to have that super cycle? Is that what is priced in? that's what's priced in melissa and that's exactly the problem look i love apple as much as everybody loves apple i'm a devout apple user the products are great i sometimes hear this straw man argument when i'm posed as being hyper bearish and by the way i'm not particularly bearish um i i just i just think the stock is is somewhat overvalued um but but i i keep hearing people say you're crazy, no one's going to switch from Apple to Android.
13:09And of course, they're not going to switch from Apple to Android. That's not the point. The point is, unless you get faster revenue and earnings growth, the stock at 31 or 33 times earnings right now is too expensive. And ultimately, it's going to underperform over the long term because other things will grow faster. Even the rest of the S &P 500 is going to grow faster. So what was priced in, and especially, by the way, the peg ratio at Apple compared to the rest of the Mag 7 is moonshot, right? So what was priced in a year ago when everybody got all jazzed about the Worldwide Developer Conference was a super cycle.
13:50And that depended on people taking the promised AI Apple intelligence and needing better hardware in order to run it. That requires that it runs on the phone. What we're getting closer to finding out is that Apple's gonna do really well in AI probably, but more likely if it's by partnership, it's not gonna run on the phone as likely as it is running in the cloud. And while that's great for consumers, it probably doesn't drive a super cycle. So you're left with a great company with a great consumer franchise. But as you said, with people upgrading on a normal pace of upgrades rather than a super cycle, that's probably not good enough for what's priced into the stock.
14:37So, Craig, we just talked about the hyperscalers and the amount of capital that they are spending right now and what is expected over the next five years or so. There's some estimates that like in 2029 alone, there's going to be a trillion dollars of spend. And, you know, you think about that right now, 25 percent of sales for those major companies, they are spending on the build out right now. Apple, I think it's low single digits. So as an analyst and you look at that and based on what you just said about their inability to probably have this sort of technology on their phones, has this been a massive, massive misstep on their front?
15:10And is it the sort of thing that will keep them in the penalty box for a long time? Well, you can see it both ways. I mean, right. One of the things that was appealing about Apple for a while was they weren't spending the same kind of CapEx and therefore you have a good free cash flow story. I do think that, you know, and Tim Cook has essentially said so, that we're going to have more CapEx and they're going to have to invest more aggressively in going forward on AI. And so will it start to look like meta and the kinds of chat GPT types of numbers? Of course not. But it is likely to be substantially more spending than what we've seen in the past.
15:54You know, I don't know. Is that enough to really make it an AI growth story? I'm not sure. It's certainly not going to be in that league. But the people who have said Apple's really well positioned for consumers to to get their AI on Apple devices are absolutely right. I mean, it is. Again, it's just just a question of what's priced into the stock. Craig, always great to speak with you. Thanks so much. My pleasure. Good to see you, Melissa. All right. Mike Coe, options market, options flow, mostly bullish here on Apple? Yeah, I mean, it was mostly bullish today. We did see calls out facing puts by a little bit more than two to one.
16:33You know, I will point out there were a couple institutional prints, but most of this flow is really retail and going into the event. And people will still have an opportunity, of course, because it's going to be an intraday announcement. So there is that. It's end of week activity that we're seeing the 240s, 242 and a half and 245 calls all expiring this coming Friday that are seeing the most activity. Those 240s traded about 80 ,000 contracts or so at about two bucks a contract. But I think to everybody's point here, I mean, they would essentially exhaust all of their free cash flow to catch up on the CapEx side to, say, Amazon.
17:07So they have a lot of work to do, and their top line growth is about 4.5%. 240, 245, those are key levels of the stock. Mike's pointing out from the options market, they're important for the stock because that's really where you get to, you know, back to more or less kind of this key resistance level that I think you get through. It should be noted Apple's outperformed the S &P since late May, early June. And I realize, you know, I'm picking some spots here. A lot of that has to do with the China overhang and some of it. But that's kind of my point even, is that Apple starts to outperform as you all the stuff that's priced in that's bad, that's not happening.
17:41We know that. The fact is the Google antitrust dynamic revealed a couple of things. First of all, defaults are allowed. And so therefore, that 20 billion payment remains. The exclusivity is not allowed, which means that Apple every year plays gatekeeper and can renegotiate every year. None of that's in the stock price. If you can't, I mean, this is where I'll save the righteousness. I just, it's what we've all been saying tonight. Apple is the gatekeeper in terms of how people are using AI. That's most people on the small screen. The same thing we were saying about the small screen when it was time to do everything else on the small screen.
18:15So sitting back, it's not what we wanted for Apple as shareholders, but it doesn't mean that 95 % margins aren't theirs for the taking on tack. Yeah, well, the one thing I'll just say, if there's no iPhone super cycle, right, then you have to go back to services. And services going forward is going to be driven by AI on the phone. If that is in the cloud, then that's the thing that is not particularly difficult to replicate if you are any other phone maker. And so that is an issue in China where they are losing market share right now. Right. And so when you think about how the Chinese operate on phones like this for services, Apple's service revenue grew 13 percent last quarter.
18:55It's 24, 25 percent of their total revenue. I don't think that sort of growth in a higher margin business. Right. Is the sort of thing that justifies probably the multiple it is right here. So to me, if it's not a growth business, then it doesn't deserve to trade at a growth multiple. And so I don't know. I think it's really a wait and see. You know, we were saying that last year, 2024, WWDC, this is going to be a 2025 story. If they could ever fix out Apple intelligence, it really feels like it's a second half 2026 story right now. All right. Well, shares of Amsterdam based AI cloud company Nebius surging after saying it has inked a nearly 20 billion dollar AI infrastructure deal with Microsoft.
19:33Shares of Nebius already up 130 percent this year before the news. shares in Microsoft at last check, not really moving on this, but obviously Nebius is a smaller company of the two. Meantime, coming up, a check on the China trade, the group on the move with tech leading the charge, the names in the green, despite some disappointing data out of the mainland, plus Robinhood and Apple oven surgeon on news of their S &P inclusion, what the addition will mean for names in the long run when Fast Money returns back in two.
20:09Welcome back to Fast Money. Shares of Tesla down about a percent today after new data showed the EV maker's U.S. market share dropped to its lowest level since 2017. According to Reuters, the company, which once owned more than 80 percent of the country's EV market, held less than 40 percent in August. The drop comes as rivals roll out new models and Tesla focuses on other businesses like robo taxis and humanoid robots. GM, for one, has increased its share in EVs. Tim? I mean, I don't know if you see this as a huge deal because most of the market valuation of Tesla is not in vehicles. And most of the market share of GM is in ICE cars and or at least, you know, I don't know what to make out of it other than this is exactly where we said it was going to be.
20:55And if you value these things as auto companies, they're both mismarked. GM is wildly cheap. Tesla is even more wildly expensive. And the argument for Tesla bulls continues to be it's all these other businesses that continue to not happen. So there's no question BMW is making a superior luxury, at least as you get into the EV space. There's no question the mass market that Tesla has created, it hasn't really created. That said, Tesla has been by far the leader, is by far the leader. I'm just not buying the stock. I tip my hat to what they've done in the EV space. Yeah, do you tip your hat to what they've done in the Optimus space and the robots or the, you know, the robot taxi?
21:41I mean, we don't know, right? So it's a$1.1 trillion market cap company. And I think what's interesting here is that the Tesla bulls now agree with the Tesla bears is that the best days for their EV business are behind them, right? And it really is all about these new technologies, which is why you are starting to hear the potential for Tesla to buy XAI, right? We know that they want to invest in it. We also know this proposed plan for compensation for Elon Musk is like, okay, he could make a trillion dollars if he doubles the market cap. Well, how do you do that? It's a bit of a shell game right now.
22:11He's also got to deliver robots and robo taxes and commercialization. So he's going to make the case right now why XAI deserves to be part of this company. The problem is they're losing a billion dollars a month in XAI. What would shareholders like? They'd have to be crazy to agree to that sort of thing. And why buy the cow when you get the milk for free? One of the reasons why is I think he wants to just. I've heard that before, by the way. That expression. There was a time. There was a time. Yeah, but my point is, is like he could have access to XAI's technology. I mean, like, you know, and not that they could just like.
22:43But look at how this company has operated for years and years. They bought SolarCity years ago when that thing was not doing particularly well. So to me, this is like going to be a big mashup. And it's going to be one of those things that it's going to be really hard to tell what is driving the valuation. But make no mistake about it, their EV business is kaput. All right. Let's get to Robin, to each's opinion, right? Robin and Apple 11 both soaring to record highs today on news. They'll be joining the S &P later this month. Both stocks have already solid returns this year. But will inclusion in the benchmark keep those gains coming?
23:13Mike, what kind of activity have you seen in either of these? I mean, a lot of activity. I mean, there was a big pickup in the options volume of both of these names, unsurprisingly. I will say this was a happy surprise for us. We happen to have fairly big positions in both of them. So that was good news. Somewhat unexpected, I would say. But look, I mean, you know, what's going to happen is this is essentially going to get absorbed. And then it's just going to be back to whether or not you happen to like the companies. I think Robinhood's really been doing a great job with their business. I haven't followed it quite as closely, but I will say that, you know, once you get inclusion, then that sort of one trick pony is over.
23:54So I think we've probably got about three days of catch up going on and then it's going to be, you know, back to fundamentals. All right. Coming up, descending summit. Shares plunging as the biopharma stock hits a snag with its lung cancer drug study. The results from around the world, what it means for the stock's next move. You're watching Fast Money Live from the Nasdaq market site in Times Square. Back right after this.
Read the full transcript
24:24Welcome back to Fast Money. Shares of Summit Therapeutics plunging more than 25 % after results from its lung cancer drug showed differing results for U.S. and China patients. CNBC's Angelica Peoples has got more on this. Angelica. Hey, Melissa. Well, as you know, the debate all along here has been whether Summit's lung cancer drug would look as impressive outside of China. And those doubts are just getting louder with these results that we saw over the weekend. Remember that Summit made the big splash last year after it said that its drug beat Merck's Keytruda in a head-to-head study, but that was conducted exclusively in China.
24:58And that, of course, though, sparked a ton of excitement for both Summit's drug and others like it that go after the same target as Keytruda, plus the same target as Roche's Avastin. But the fresh data that we saw from this global phase three trial casting doubts on the prospects for the drug overseas, particularly here in the U.S. So let's get through it. Summit's drug plus chemo cut the risk of tumor progression by 45 percent in China, but only by 33 percent in Western countries. And the drug did not show that it could keep people alive much longer than chemo alone. And that's something that the FDA will want to see in order to approve the drug.
25:33Now, Summit did suggest that the overall survival benefit was improving over time. But Lyric analysts saying that they believe it's unlikely the FDA will grant approval based on these results, nor that Summit will partner the drug at the substantial valuation expected by investors. So a lot of disappointment here, Melissa. Angelica, how does this sort of impute on some of the other companies that were hoping to do a lot of research and trials in China as they are licensing drugs from China, buying molecules in China? How does that sort of change the landscape with these results being so disparate in terms of the results in Asian patients and non-Asian patients?
26:10I do think there are certainly questions about whether this is a class effect. Is this something, you know, just a mechanism that's not really going to live up to the hype? Or is this specific to the summit data? Because remember, it's a little bit wonky here where they had to start, they had this trial ongoing in China. And so those patients were receiving the drug much longer. And then they started recruiting patients in Western countries, including the U.S. So the question is, is it a data problem? Is it just, you know, will these results get better over time? Or is it a class problem? You did see some weakness today in BioNTech.
26:43Of course, that's another company that's working on this. And so I think there are some questions, but certainly companies are going forward. Angelica, thanks. Angelica Peebles. Mike Coe, what'd you see in Summit today? A lot. I mean, look, typically when you have these pre-revenue biotech companies, there's a lot of people who are speculating in the options, and a lot of people had been. We saw a big roll down and out. That's not a good thing, typically. That's when somebody who previously made a sizable upside bet has to go further out in time and then reduce their call strike significantly.
27:15But they only went out about a week on a 9 ,000 lot. Everything else, the next five top options volumes were all on the foot side. So it seems like a lot of the speculation that had been bullish has turned pretty bearish now. And if you're following Mike's advice on the options side, or at least looking at the options market as the way to play, not only does that seem sensible, but it's pretty clear here that the bottom line is that the company is going to continue to follow the Western kind of data points view, patients view, and that they're going to continue to go along the same line they've been going along.
27:47And that if there's, you know, there could be opportunity in an outcome like this that probably is best played in a risk managed way. All right. Another reminder here. Fast Money Live is coming back. A special Trading the Holidays live event happening right here at the NASDAQ on December 11th. Scan the QR code on your screen or head to cnbc.com slash fast money to get your tickets. New York during the holidays, a front row seat to Fast Money Live. We are trading 2026 in December. I'm disappointed, Tim, that you didn't get a hat. I think just the same way that Santa magically makes stuff appear, I believe this hat could still appear before I stop talking at some point.
28:22All right. Well, imagine me putting on this great furry red hat and just how exciting it's going to be. Trading the holidays, I bet it's going to be a white Christmas that day. I mean, there's going to be so much cheer in the room. Dan's going to be gentle. I have a great idea. Maybe Sandy's listening or Mary. I mean, what if we roll out our acronyms for 2026 or something like that? At the Fast Money Live. All right, I'm on it. Start thinking. Big gift. Big fun. Coming up, the China trade in the green. The tech names on the move and what disappointing export data means for the next move out of the mainland.
28:55Do not go anywhere. Fast Money is back in two.
29:06Welcome back to Fast Money Stocks. Kicking off the week in the green as investors brace for more inflation data. The Dow jumping more than 100 points. The S &P up two-tenths of a percent. And the Nasdaq climbing nearly half a percent, closing at a record high. Gold also hitting a record today. The precious metal now up nearly 40 percent this year. While China's big tech stocks also higher, with names like Baidu, Alibaba and EV maker Xpeng leading the way, the move comes even as the world's second largest economy said it shipped 33 percent less to the U.S. in August than in July. Total growth export growth dropped to its slowest pace in six months.
29:39For more on what this means for China's top names, let's bring in Safinat, chief investment strategist and honorary professor at the Chinese Academy of Sciences, John Rutledge. John, great to see you. Great to see you, Melissa. How are you? Good. The headline looks dire, but at the same time, you look underneath and they are exporting a bunch to other countries, Southeast Asia, to Europe and elsewhere. So how do you interpret this? Well, you know, actually, Melissa, the trade surplus is up. It's up 4 percent year over year, but it's less than July. but it's still up and only to the U.S. is down 33 percent.
30:17If you look at the other parts of the world, you've got, you know, 20s and 30s on Europe and Asia and Africa. So what's happening is whoever imposes the tariff, the other guy can still sell to everybody else in the world. So you're a minority player. We're a small piece of trade. That means that the export, the tariffs hurt us a lot more than they hurt them. Yep. And so you have that. And then also you have this rally, which you're showing on your screen, you know, in Chinese stocks. And do you think that this puts into jeopardy any sort of stimulus that we might have been expecting from the Chinese government?
30:56No, I think, you know, they've got they've got GDP this year so far, 5.3, which they'd like to see a little bit more. It's running a little lower than that right now. I think you're going to see some stimulus because right now export prices are falling producer prices, CPI is falling, and they still have the real estate problems to work through. So I think you're going to see a lot more stimulus out of China. But of course, they've got all these friends in the global south now that they can sell things to. Solar panels, especially, is where they dominate, and electric vehicles right behind it, and also steel exports are up.
31:31So China is doing a lot better than I'm sure Mr. Trump would like them to be doing right now. Hey, John, it's Tim. Thanks for joining us. I guess my question to you is on the governance side. I think there are a bunch of institutional and retail investors in this country that are fearful to invest in China, not just because of, you know, C-suite governance dynamics, but also even geopolitics, geopolitics between the U.S. and China. Many fearing that the U.S. government might ban many of these Chinese companies that are traded in ADR land. But certainly structural dynamics are just about owning the underlying.
32:02Any thoughts on this? You don't need to be a trader per se, but having a view on just how important the the functional trading markets for these names continues and how important that might be for the Chinese government as much as the U.S. government. Sure. You know, I think that investing outside your own native environment is very risky because you just don't really know what what you're doing. It's good to invest in a place that has rule of law and judges in long black robes, neither one of which they have in China. President Xi could wake up one morning with a stomachache and impose some kind of a rule on Alibaba, like he did for Jack Ma some years ago, and wreck your investments.
32:43So I normally advise non-specialists to stay away from foreign assets. And we certainly have plenty of choices here in the U.S. But Alibaba right now, for somebody like me who spent a lot of time in China, is very interesting. New chip, cloud, data centers, a lot of things going for them these days. And so I think it's interesting for someone who is not a tourist. Hey, John, back to that export data. Is it likely that they can kind of sustain this ability to export to places other than the U.S.? And I guess, like, what sort of leverage does it give the Chinese at this point? Because we spent a lot of time talking about rare earths, you know, a few months ago, and that seemed to change the tenor of the conversation.
33:22I'm just curious, this export data seemed pretty surprising. Yeah, it is. Well, it's surprising both the U.S. side how low, but also the other parts of the world so high. A good bit of what is being exported from China will then bounce back into the U.S. from someplace else. Trying to stop trade with tariffs is like trying to hold back the ocean tide with your hands. You know, it just the goods flow right around you. But I do think that I do think that you're going to see the data continue to be weak overall for trade. And China still to be struggling with growth. But again, they're not in an emergency situation here.
34:02And they will have been glad to see these numbers come out. John, great to see you. Thanks. Great to see you, Melissa. John Rutledge. So what do you make of this run in Chinese stocks? I think it's going higher. And I look at the levels on the stocks. You're pushing up against both November of 24 levels, where these stocks got up to, and then March of 24. or whether you're looking at BABA, whether you're looking at Baidu, whether you're looking at the K-Web. And John makes some great points. I mean, I'll just say I think most U.S. investors, as someone that runs an international ETF, where BABA is actually the largest position, I think U.S.
34:35investors are underweight international. And I think you can invest in the U.S. in companies that are traded here in ADR form. iDevo, my ETF, owns only those companies. And this isn't about being a sales pitch. This is the point is I think people have been underweight and scared to invest in a lot of these markets, Whereas part of the reason for Alibaba is that no longer do we feel that the government has them under their thumb. This is a world class tech company where Ali Cloud is probably as exciting of a play as we're putting into a lot of the Mag 7 here. But I think international investing also in a lower rates environment and also where the dollar is going weaker is a place that people need to be.
35:09Coming up, hunger pains for shares of Cava, Sweetgreen and Chipotle. The fast casual restaurant names continue their decline. What is weighing on the stocks and can they get their bite back? Fast Money is back in two.
35:28Welcome back to Fast Money. Fast casual restaurant stocks continuing their declines today. Kava, Chipotle, Sweetgreen all hitting their lows of the year. Sweetgreen is now down nearly 75 % in 2025. The company is under pressure as consumers seem to lose their appetite for eating out, or at least for eating out at these price points. So we were just discussing how much like a Kava Bowl cost, which is like 17 to 20 bucks. Yeah, and I obviously eat a lot of salads. So this is something that is near and dear to my heart. Like when you look at the way that these stocks have sold off, it is truly astounding.
36:01But make no mistake about it. I mean, these companies are losing a lot of money. And if you think that they actually had a corner of the quick serve, what is this, fast serve, quick serve, whatever, whatever. Whatever this category is, expensive. This was the zeitgeist, though, in this space, right? And you can't get rid of these sorts of stocks. So to me, they're probably getting close to pretty interesting, especially if you could ever see some sort of turn in those same sort of sales or the profitability levels. But right now, sadly, it looks no touch. But if you want to close your eyes and just take a shot, definitely in the sweet green, it could be kind of interesting here.
36:32Mike, you were shaking your head vigorously. So I'm not really sure where you fall on this discussion. He loves a good salad. Well, I should eat more salads like Dan. And he looks good for having done it. I'd look a lot better if I did. Look, Sweet Greens is not profitable. It has not been profitable. I mean, it did trade 10 times its average daily put volume. That doesn't surprise me. Chipotle, on the other hand, that is profitable. And it has always traded at a multiple that was kind of hard to get your arms around. But now it's starting to close in on just over 30 times forward. I think it gets down to that level.
37:05But that one begins to look a little attractive to me. Chipotle does feel different from the other two in terms of their history of execution and customer loyalty. But it feels different from the other two right now. If I'm channeling my A &R Carter right now, that's not a chart you're buying. You don't need to buy it. And this stock's been halved from really the beginning of the year. It's trades at a 25 percent discount to its five year. That's the whole reason probably not to buy it. I don't know. As someone that missed it on the way up, I'm hoping to maybe get it someplace lower. And do not miss Jim's exclusive interview with the co-founder and CEO of Kava at the top of the hour on Mad Money right here on CNBC.
37:43Meantime, coming up on Fast, how cybersecurity company Gen Digital hopes its recent acquisition of MoneyLion will make finance more personal for consumers and help them take control of their money. The CEO will join us next. More Fast Money in two.
38:05Welcome back to Fast Money. Gen Digital shares rising more than a percent after hosting its analyst day here at the Nasdaq market site. The company recently closing a$1 billion deal to acquire MoneyLion, combining that company's consumer finance tools with Gen Digital's credit and identity protection portfolio, which includes Norton and LifeLock. For more, Gen Digital CEO Vincent Pellet joins us here on set. Vincent, great to have you with us. We're familiar with MoneyLion and we're familiar with the other brands. How do you make the case for them being together? It's fantastic. Today we had the first opportunity to explain to investors how Gen Digital, the family of trusted brands like LifeLog that tracks your financials, track your credit score, monitor any deviations, financial fraud, bringing that together with MoneyLion that helps you then manage and grow your financials.
38:51And so we now provide our consumers kind of an end-to-end along their financial journey from building up your credit, leveraging your credit for whatever financial products you want, and then ultimately protecting your asset that you acquired. And now we're able to provide this kind of new category called secure financial wellness for our consumers. So this is all about cross-selling? It's all about increasing the value to the customer and increasing the number of products, if you want, that we sell to our consumer. But we sell it also into a membership kind of you get into the platform and then you can access higher level of services depending on your financial needs.
39:26Vincent, give us a sense. You had this analyst today. You know, you're a company that you have brands that you own that a lot of consumers are very familiar with. And the same thing on the Moneyline standpoint. What were some of the questions that you were getting about like Mel just asked you about the cross selling opportunities. But like how are investors, how are analysts thinking about this combination? I think we really have two set of investors, those who are familiar with the fintech marketplace and the other one that is familiar with CyberSecret. And as we bring it together, we had to explain what secure financial wellness means.
39:56And if you look at the average consumer have seven to eight products, consume seven to eight financial products. Half of them comes outside of their primary banks, shopping on Internet platform, et cetera. And we bring with Jen the trust, the confidence that you can really select what you need. And then MoneyLion brings a marketplace that has over 1 ,300 partners offering very different financial products to those consumers that are on our platform. Vincent, so how do you think about growth? And how do you think about where the combination of these assets, these synergies, this cross-selling, does it create, you know, is there a hockey stick out there?
40:33How do you see your business, especially because these are trusted brands at a time when, if anything, cybersecurity, especially I'd say on the individual level, all we do is talk about the enterprise. But I think individuals are as aware as anyone. That's absolutely something that's not really well known by all investors, that when we talk about security, it's 99 % of our enterprise. We're solely focused on the consumer. As you know, the threat landscape is evolving rapidly. A lot of the old malware are now evolving as full scams and new financial assets and what matters for you online. is at risk.
41:04On the other side, we have another transformation happening. More and more consumers are shopping for financial products differently than outside of their primary bank in an open ecosystem. And I think bringing it together for us is positioning Jen into a faster growing market and trying to leverage those two transformation, an evolving threat landscape and an evolving digital financial landscape. So in let's say five years, how do you see your consumer in terms of what the overlap of products are? Will all your consumers be customers touching all these points of your business? Or will you have separate LifeLock customers, separate MoneyLion?
41:39How do you see the breakout? Great question. And MoneyLion developed, like they've had 10 years of developing what we call a white label architecture. Their technology, probably the best in the fintech environment, is able to be embedded into everybody's platform. And so we're going to embed MoneyLion financial architecture into each one of our brands, Norton, LifeLock, Avast, and be able to provide this helpful decision-making on the financial side at the right moment of the customer journey. I think following the brand customer journey or the consumer customer journey is a very important factor in today's world in digital finance.
42:14Vincent, thanks so much for joining us. We appreciate it. Absolutely. Of Gen Digital. So GEN, by the way, is the ticker in case you're wondering. I have a relationship with Moneyline, and I've gotten to know them. And it's interesting to get to know more about this combination. But when I look at Jen, I say to myself, this is a company that's doing double digit earnings growth and is trading about 12 times earnings. So in the market where folks are really OK with paying up for fintech companies, we've seen some crazy multiples. That looks pretty interesting to me. Up next, final trades.
42:52It's time for the final trade. Michael Coe. Michael. Yeah, I still like Robin Hood, but if you want to get a little yield out of it, think about selling some upside coverage calls. Timote. Yeah, I like this breakout in China Tech. I think Baba is the way you're most confident right now. Dan Nathan. I hate when you call me Daniel. I'm usually in trouble a little bit. No, that 10 digital story is kind of interesting. Double-digit earnings go to 83 % gross margin. So Jen looks interesting. All right. Thank you for watching Fast Money. See you tomorrow on The Exchange at 1. Mad Money with Jim Cramer starts right now.
43:30All opinions expressed by the Fast Money participants are solely their opinions and do not reflect the opinions of CNBC, NBC Universal, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet, or another medium. You should not treat any opinion expressed on this podcast as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion. Such opinions are based upon information the Fast Money participants consider reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such.
44:04To view the full Fast Money disclaimer, please visit cnbc.com forward slash fastmoneydisclaimer.
From the publisher
The AI trade gets a boost, even as data suggests companies are slowing down adoption. What the pullback could mean for semi stocks, and the broader tech space. Plus China stocks jumping to start the week, despite disappointing export data for the country. The names leading the climb, and what it means for the next move out of the mainland markets.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
